Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Levi Garraway
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Foundation Medicine
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
NA
The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients
Among the diseases that account for most deaths in the United States, cancer is noteworthy for being a disease of the genome. This recognition is bringing forward a new paradigm for cancer care, where the choice of treatment is guided by information contained in the genome of each cancer patient and her tumor. In this grant, we will develop and implement a robust framework for the generation of genome sequencing data from 'real-world' tumor materials, interpretation of the vast amounts of information that emerge, and the incorporation of relevant genomic information into the care of cancer patients and their families. This effort may provide a widely applicable framework for clinical sequencing that speeds the advent of personalized cancer medicine.
Filed on December 16, 2014.
Tell us what you know about Levi Garraway's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Levi Garraway”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | >$600,000 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $80,000 - $99,999 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | >$600,000 |
| Levi Garraway | Harvard Medical School | Conflict of Interest | Foundation Medicine, Inc. | $80,000 - $99,999 |
| Levi Garraway | Massachusetts General Hospital | Conflict of Interest | Foundation Medicine | $80,000 - $99,999 |
| Levi Garraway | Massachusetts General Hospital | Conflict of Interest | Foundation Medicine | Value cannot be readily determined |
| Levi Garraway | Harvard Medical School | Conflict of Interest | Foundation Medicine, Inc. | >$600,000 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.